知镜 Cognispect · 医学文献与研究工作台

Population health and epidemiologic trends in weight gain among people with HIV.

Bourgi K.
Current opinion in HIV and AIDS · 2026-09-07 · PMID 42770279

文献摘要

Purpose of review The epidemiology of weight among people with HIV (PWH) has shifted from wasting to overweight and obesity. This review summarizes population trends in weight, antiretroviral therapy (ART)-associated weight trajectories, subgroup heterogeneity, and cardiometabolic consequences of weight gain among PWH. Recent findings Weight gain after ART initiation is common and occurs against a background of secular increases in obesity prevalence. Greater gains are often observed with contemporary integrase strand transfer inhibitor (INSTI)-containing and tenofovir alafenamide (TAF)-containing regimens, although interpretation is complicated by return-to-health and the weight-suppressive effects of older regimens (efavirenz and tenofovir disoproxil fumarate). Weight changes after ART switch are usually modest, and discontinuing INSTI or TAF rarely reverses established gain. Black women and individuals with advanced HIV disease experience greater gains, and substantial early increases in weight have been associated with diabetes, metabolic syndrome, hypertension, and dyslipidemia. Summary Weight gain among PWH is heterogeneous and should be interpreted in the context of baseline nutritional status, ART exposure, and population setting. Future studies should identify which patterns of weight gain predict adverse clinical outcomes and evaluate interventions that reduce metabolic risk.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。